Predicting Cross Reactive Immunological Material (CRIM) Status in Pompe Disease Using GAA Mutations: Lessons Learned from 10 Years of Clinical Laboratory Testing Experience

Documenti analoghi

• Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
  di: Bali, Deeksha S., et al.
  Pubblicazione: (2015)
• Atypical immunologic response in a patient with CRIM-negative Pompe disease
  di: Abbott, Mary-Alice, et al.
  Pubblicazione: (2011)
• Characterization of immune response in Cross-Reactive Immunological Material (CRIM)-positive infantile Pompe disease patients treated with enzyme replacement therapy
  di: Desai, Ankit K., et al.
  Pubblicazione: (2019)
• P716: Post-translational processing of GAA protein associated with GAA variants may explain the clinical variability observed amongst Pompe disease patients
  di: Shelly Goomber, et al.
  Pubblicazione: (2025-01-01)
• Letter to the Editors: Concerning “CRIM-Negative Pompe Disease Patients with Satisfactory Clinical Outcomes on Enzyme Replacement Therapy” by Al Khallaf et al
  di: Prater, Sean N., et al.
  Pubblicazione: (2013)